TY - JOUR
T1 - Invasive fungal infections in high-risk patients: report from TIMM-8 2017
AU - Pagano, Livio
AU - Mayor, Susan
PY - 2018
Y1 - 2018
N2 - Trends in Medical Mycology (TIMM) is the biennial meeting of the Infectious Disease Group of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Confederation of Medical Mycology (ECMM). It brings together clinicians and researchers from across the world to share the latest R&Ds in medical mycology. Despite advances in treatment, invasive fungal infections remain a major cause of morbidity and mortality in certain high-risk groups of patients, particularly in immunocompromised patients, including those undergoing solid organ transplantation and those with acute leukemia. The challenges for clinicians are now compounded by the rapid development of multidrug resistance. The latest data and approaches to identifying patients at high risk for invasive fungal infections, ensuring early diagnosis and achieving effective treatment, including when and how to use therapeutic drug monitoring with azoles, were shared with >1000 clinicians and researchers from around the world attending the eighth TIMM, held in Belgrade, Serbia, in October 2017 (TIMM-8 2017).
AB - Trends in Medical Mycology (TIMM) is the biennial meeting of the Infectious Disease Group of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Confederation of Medical Mycology (ECMM). It brings together clinicians and researchers from across the world to share the latest R&Ds in medical mycology. Despite advances in treatment, invasive fungal infections remain a major cause of morbidity and mortality in certain high-risk groups of patients, particularly in immunocompromised patients, including those undergoing solid organ transplantation and those with acute leukemia. The challenges for clinicians are now compounded by the rapid development of multidrug resistance. The latest data and approaches to identifying patients at high risk for invasive fungal infections, ensuring early diagnosis and achieving effective treatment, including when and how to use therapeutic drug monitoring with azoles, were shared with >1000 clinicians and researchers from around the world attending the eighth TIMM, held in Belgrade, Serbia, in October 2017 (TIMM-8 2017).
KW - antifungal resistance
KW - azole drug monitoring
KW - invasive fungal infections
KW - prophylaxis
KW - antifungal resistance
KW - azole drug monitoring
KW - invasive fungal infections
KW - prophylaxis
UR - https://publicatt.unicatt.it/handle/10807/125227
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85068827936&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85068827936&origin=inward
U2 - 10.4155/fsoa-2018-0019
DO - 10.4155/fsoa-2018-0019
M3 - Article
SN - 2056-5623
VL - 4
SP - FSO307-FSO307
JO - Future Science OA
JF - Future Science OA
IS - 6
ER -